T. Rowe Price Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
T. Rowe Price Investment Management's LLY Position: Q1 2026 in Review
T. Rowe Price Investment Management reduced its Eli Lilly (LLY) stake by 6.7% in Q1 2026, selling an estimated $75.3M and leaving 1,026,556 shares worth $944M. The position accounts for 0.65% of the portfolio, ranked #31.
T. Rowe Price Investment Management first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.18B in Q4 2025. 4,363 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- T. Rowe Price Investment Management held 1,026,556 shares of Eli Lilly worth $944M as of Q1 2026.
- T. Rowe Price Investment Management sold 74,308 Eli Lilly shares in Q1 2026, an estimated $75.3M.
- Eli Lilly made up 0.65% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #31 holding.
- T. Rowe Price Investment Management first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
- T. Rowe Price Investment Management's Eli Lilly position peaked at $1.18B in Q4 2025.
- 4,363 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.